Dexmedetomidine for Every Cesarean Delivery … Maybe Not?

Abstract

(Can J Anesth/J Can Anesth. 2019;66:751–754) Perioperative shivering is a commonly observed clinical problem for women undergoing cesarean delivery (CD). The median incidence of shivering in patients having a CD with epidural or spinal anesthesia is estimated to be 52%. Previous studies have analyzed pharmacologic agents such as meperidine, butorphanol, clonidine, fentanyl, tramadol, and dexmedetomidine and their ability to reduce shivering following neuraxial anesthesia. However, side effects including nausea, hypotension, vomiting, and excessive sedation limit the utility of these agents.

Multi-Indicator Intelligent Monitoring of Clinical Observations to Reduce Cesarean Section

“…It is tightly observed on the production of huge children. When the production process is normal, try to choose vaginal delivery to ensure the safety of the mother and the child [ 17 – 19 ].…”

“…It is tightly observed on the production of huge children. When the production process is normal, try to choose vaginal delivery to ensure the safety of the mother and the child [17][18][19]. , and the difference in Cesarean section rate in the two groups was significant (P < 0.05).…”

Factors Driving the Difference in Quality of Recovery Scores Between Scheduled and Unscheduled Cesarean Delivery Patients

“…The experience may cause emotional and physiologic distress and further contribute to a sense of loss of control. 14 Promising pharmacologic treatments, such as intravenous dexmedetomidine need more definitive study. 15 Although achieving intraoperative normothermia is sought, the treatment of shivering is complicated and, counterintuitively, active warming may not be effective.…”